SCHEDULE: Vanguard Group Amends Inogen Stake to Zero

The Vanguard Group has filed an amended Schedule 13G for Inogen Inc., reporting 0% beneficial ownership following an internal realignment.

Summary

• An Amendment No. 10 to Schedule 13G has been filed for Inogen Inc. common stock.
• The Vanguard Group now reports 0% beneficial ownership of Inogen Inc.
• This change stems from an internal realignment within The Vanguard Group that occurred on January 12, 2026.
• As a result of the realignment, certain Vanguard subsidiaries or business divisions will now report their beneficial ownership separately.
• These subsidiaries are expected to continue pursuing the same investment strategies as before the realignment.
• The Vanguard Group, Inc. no longer holds or is deemed to hold beneficial ownership over these securities.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral procedural update. It clarifies a change in reporting structure for beneficial ownership by The Vanguard Group, not a change in investment thesis or operational performance for Inogen Inc.

Positives

• The underlying investment strategies for Inogen Inc. shares held by Vanguard's subsidiaries are expected to remain consistent, suggesting continued institutional interest.

Negatives

• The reported 0% beneficial ownership by The Vanguard Group as the primary entity could be misinterpreted by some market participants as a complete divestment, despite being a reporting change.

Risks

• There is a potential for market misinterpretation regarding The Vanguard Group's overall investment in Inogen Inc., given the parent entity's reported 0% beneficial ownership.

Future Outlook

No forward-looking statements or guidance regarding Inogen Inc.'s operational performance or financial health are provided.

Management Comments

• The securities were acquired and are held in the ordinary course of business and not for the purpose or effect of changing or influencing control of the issuer.

Industry Context

StockSavvy.ai notes that internal realignments and subsequent changes in reporting structures are common among large asset managers like The Vanguard Group. This filing reflects a procedural change in how beneficial ownership is attributed and reported, rather than a change in investment strategy or a divestment from Inogen Inc. by Vanguard's broader family of funds.

Stakeholder Impact

• Shareholders may initially perceive a reduction in institutional ownership, but understanding the internal realignment clarifies that underlying holdings by Vanguard's subsidiaries likely persist.
• Investment professionals will need to track beneficial ownership through Vanguard's disaggregated filings to get a complete picture of their overall stake.

Key Dates

Keywords

Inogen Inc, Vanguard Group, Schedule 13G/A, beneficial ownership, institutional ownership, SEC filing, internal realignment, common stock